ID: ALA596787

Max Phase: Preclinical

Molecular Formula: C27H20ClN5O4

Molecular Weight: 513.94

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 7-N-Chloroacetyldemethyllavendamycin Pyrrolidine Amide
Synonyms from Alternative Forms(1):

    Canonical SMILES:  O=C(CCl)NC1=CC(=O)c2ccc(-c3nc(C(=O)N4CCCC4)cc4c3[nH]c3ccccc34)nc2C1=O

    Standard InChI:  InChI=1S/C27H20ClN5O4/c28-13-22(35)29-19-12-21(34)15-7-8-18(31-24(15)26(19)36)25-23-16(14-5-1-2-6-17(14)30-23)11-20(32-25)27(37)33-9-3-4-10-33/h1-2,5-8,11-12,30H,3-4,9-10,13H2,(H,29,35)

    Standard InChI Key:  UBUVJMWIVJOQFK-UHFFFAOYSA-N

    Associated Targets(Human)

    Quinone reductase 1 1746 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    BE 127 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 513.94Molecular Weight (Monoisotopic): 513.1204AlogP: 3.63#Rotatable Bonds: 4
    Polar Surface Area: 125.12Molecular Species: NEUTRALHBA: 6HBD: 2
    #RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
    CX Acidic pKa: 11.74CX Basic pKa: 0.47CX LogP: 2.27CX LogD: 2.27
    Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.40Np Likeness Score: -0.20

    References

    1. Cai W, Hassani M, Karki R, Walter ED, Koelsch KH, Seradj H, Lineswala JP, Mirzaei H, York JS, Olang F, Sedighi M, Lucas JS, Eads TJ, Rose AS, Charkhzarrin S, Hermann NG, Beall HD, Behforouz M..  (2010)  Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.,  18  (5): [PMID:20149966] [10.1016/j.bmc.2010.01.037]

    Source